Mandate

Vinge advises the founders of Modular Finance in connection with a transaction with Sprints

Vinge advises the founders of Modular Finance in connection with a sale of approximately 40% of the shares in the company to Sprints.

Modular Finance is a SaaS company focusing on the financial markets in the Nordics and the United Kingdom. Through two business areas, Banking & Finance and Investor Relations, a range of niche products is offered with a focus on unique data sets and user-friendliness.

Sprints has a team founded and led by Swedes but headquartered in the UK, and is a focused investor in tech-enabled companies with prior experience as investors in Hemnet and existing investments in companies such as Teamtailor, Planhat, Vinted and Revolut.

The company’s founders Måns Flodberg, Rasmus Holm and Petter Hedborg will retain the majority of their shares and will remain fully involved over the coming years. Rite Ventures which has been a partner since 2014 will also keep the majority of their shares.

Vinge’s team consisted of partners Christina Kokko and Karl Klackenberg together with Viktor Lennartsson, Egil Svensson and Gustav Persson (M&A), Victor Ericsson and Morgan Ödman (Tax), and Daniel Wendelsson (Regulatory).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025